SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-009478
Filing Date
2023-03-29
Accepted
2023-03-29 16:30:58
Documents
78
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 form20-f.htm   iXBRL 20-F 2503063
2 ex1-1.htm EX-1.1 322603
3 ex2-1.htm EX-2.1 87084
4 ex12-1.htm EX-12.1 11293
5 ex12-2.htm EX-12.2 10994
6 ex13-1.htm EX-13.1 10706
7 ex15-1.htm EX-15.1 5155
8 form20f_001.jpg GRAPHIC 30688
9 form20f_002.jpg GRAPHIC 61983
10 form20f_003.jpg GRAPHIC 62457
11 form20f_004.jpg GRAPHIC 56377
12 form20f_005.jpg GRAPHIC 67729
  Complete submission text file 0001493152-23-009478.txt   8490797

Data Files

Seq Description Document Type Size
13 XBRL SCHEMA FILE glmd-20221231.xsd EX-101.SCH 35693
14 XBRL CALCULATION FILE glmd-20221231_cal.xml EX-101.CAL 50479
15 XBRL DEFINITION FILE glmd-20221231_def.xml EX-101.DEF 164483
16 XBRL LABEL FILE glmd-20221231_lab.xml EX-101.LAB 308394
17 XBRL PRESENTATION FILE glmd-20221231_pre.xml EX-101.PRE 243381
72 EXTRACTED XBRL INSTANCE DOCUMENT form20-f_htm.xml XML 1049942
Mailing Address 16 ZE'EV TYOMKIN ST. (4TH FL.) TEL AVIV L3 6578317
Business Address 16 ZE'EV TYOMKIN ST. (4TH FL.) TEL AVIV L3 6578317 97236938448
Galmed Pharmaceuticals Ltd. (Filer) CIK: 0001595353 (see all company filings)

IRS No.: 981147233 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-36345 | Film No.: 23775630
SIC: 2834 Pharmaceutical Preparations